Medpace
MEDP
MEDP
268 hedge funds and large institutions have $2.42B invested in Medpace in 2019 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 84 increasing their positions, 89 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
268
Holders Change
+43
Holders Change %
+19.11%
% of All Funds
5.89%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
61
Increased
84
Reduced
89
Closed
18
Calls
$8M
Puts
$6.91M
Net Calls
+$1.09M
Net Calls Change
+$5.55M
Top Buyers
| 1 |
Nuveen Asset Management
Chicago,
Illinois
|
+$25.3M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$13.7M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$11.7M |
| 4 |
Renaissance Technologies
New York
|
+$11M |
| 5 |
Goldman Sachs
New York
|
+$10.7M |
Top Sellers
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$50.3M |
| 2 |
BHG
Blue Harbour Group
Greenwich,
Connecticut
|
-$47.5M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$34.7M |
| 4 |
PG
Pendal Group
Sydney,
Australia
|
-$23.5M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$20.6M |
